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1ABBREVIATIONS 
 
DMPC, dimyristoylphosphatidylcholine; DMPG, dimyristoylphosphatidylglycerol; 
DMSO, dymethylsulfoxide; DPH, 1,6-dyphenyl-1,3,5-hexatriene; eNOS, endothelial nitric 
oxide synthase; NMT, N-myristoyltransferase; CNO, nitric oxide; PC, egg 
phosphatidylcholine, PG, egg phosphatidylglycerol; TFE, trifluoroethanol; TMA-DPH, 1-
(4-(trimethylammoniumphenyl)-6-phenyl-1,3,5-hexatriene. 
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ABSTRACT 
 Endothelial Nitric Oxide Synthase (eNOS) is unique among the NOS isoforms in its 
being dually acylated by the fatty acids myristate and palmitate. Due to its N-terminus 
consensus sequence, eNOS becomes cotranslationally myristoylated through an amide 
bond between the first Gly residue and myristic acid. Interestingly, this protein can also 
become transiently palmitoylated through the formation of two thioester bonds at cysteine 
residues 15 and 26. Protein palmitoylation of previously myristoylated protein results in the 
membrane association of eNOS in caveolin-enriched domains. In this work we have 
synthesized the first 28 amino acids of eNOS i) non-acylated, ii) singly myristoylated, iii) 
doubly palmitoylated and iv) dually myristoylated and palmitoylated. The effect of 
acylation on the conformation of the peptides has been studied by means of circular 
dichroism and fluorescence properties of a Trp residue which has been included at position 
29. Acylation with either myristic or palmitic acid confers the peptide strech the ability to 
adopt extended conformations. Subsequently, we have studied the interaction of these four 
peptides with liposomes of defined composition by means of circular dichroism and 
fluorescence spectroscopy and their degree of insertion within lipid vesicles measuring the 
polarization of diphenyl-hexatriene (DPH) and tetramethyl ammonium diphenyl-hexatriene 
(TMA-DPH)-labeled liposomes. The acylated peptides were able to insert deeply into the 
hydrophobic core of both neutral and acidic phospholipids. Finally, our data suggest that 
palmitoylation of previously myristoylated sequences could be responsible of the partition 
into lipids rafts observed for this type of acylated proteins.   
 5
INTRODUCTION 
Protein acylation by myristic and palmitic acid is a wide occurring process which is 
involved in membrane binding as well as in cellular signaling (1). Myristoylation is a 
cotranslational and irreversible process that adds a myristic acid through an amide bond on 
the N-terminal glycine residue of the protein within a specific consensus sequence. The 
enzyme responsible for myristoylation is the N-myristoyl transferase (NMT)1 that catalyzes 
transfer of myristate from myristoyl-CoA to suitable peptide and protein substrates. To 
date, nearly twenty NMTs from fungal and mammalian sources have been identified (2-4). 
On the other hand, palmitoylation is a reversible and post-translational process. S-acylation 
occurs on cysteine residues through a thioester linkage in a wide variety of sequence 
contexts (5). This attachment is more labile than the amide linkage and facilitates the 
interaction of the acylated protein with membranes (6). Recently, it has been discovered the 
molecular identity of protein acyltransferases that modify palmitoylated proteins (5). Two 
yeast palmitoyl-acyl transferases for intracellular proteins have been identified, Erf2/Erf4 
and Akr1 that palmitoylate Ras2 and yeast casein kinase 2 respectively (7, 8). Erf2 and 
Akr1 share a common domain, the Asp-His-His-Cys (DHHC) within a cysteine riche 
domain. The finding that these unrelated proteins share a common protein domain that is 
essential for protein acyltransferases activity has lead to the identification of a functional 
ortholog of the yeast Ras palmitoylransferase, the complex DHHC9/GCP16 (9). 
Nevertheless, non-enzymatic palmitoylation in vitro has also been demonstrated as the 
palmitoylation of a myristoylated peptide with the N-terminal sequence of the p62Yes 
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protein tyrosine kinase (10), the myristoylated Giα protein (11), the 25-kDa synaptosomal 
protein (SNAP-25) (12) and small peptides of the β2-adrenergic receptor (13). By using 
artificial sequences we have obtained data which support the non-enzymatic protein 
palmitoylation within mammalian cells (14). 
The dually acylated eNOS  enzyme produces the endothelium derived nitric oxide (CNO) 
which is an important signaling molecule involved in many biological processes such as the 
regulation of blood pressure, platelet aggregation and the maintenance of the vascular tone 
both in veins and arteries. Diminished CNO production has been implicated in the 
pathogenesis of a variety of vascular disorders including atherosclerosis and pulmonary 
hypertension (15-17). The synthesis of endothelium derived CNO is a calcium and 
calmodulin-dependent process. This enzyme is dually acylated by myristic acid on the N-
terminal glycine and by palmitic acid on two cysteine residues: Cys15 and Cys26 (18-20). 
Myristoylation of eNOS is required for the subcellular location (20, 21), the efficient 
production of CNO (22) and subsequent palmitoylation (19), but it does not seem that 
myristoylation of eNOS alone could be responsible for the association of eNOS with 
membranes (23). Both myristoylation and palmitoylation are required to target eNOS to 
specialized membrane microdomains named caveolae where it is associated with caveolin 
at low cellular calcium concentrations (23, 24). The association of eNOS to caveolin leads 
to an inhibition of eNOS activity (23). The cellular stimulation with agonists that increase 
the intracellular concentration of Ca2+ promotes the binding of calmodulin to eNOS and 
relieves the inhibition of eNOS enzyme by caveolin (18).  
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 In this work we have synthesized four peptides corresponding to the first 28 amino 
acids of eNOS with different degree of acylation: non-acylated, singly myristoylated on 
amino-terminal Gly, doubly palmitoylated on the two cysteine residues and dually 
myristoylated and palmitoylated peptides. At the carboxyl-end, we have added a tryptophan 
residue in order to monitor the fluorescence properties of each peptide. Subsequently, we 
have studied the structural properties of these four peptides and their interaction with 
liposomes of defined composition. 
 
EXPERIMENTAL PROCEDURES 
 
Materials. Egg phosphatidylcholine (PC), egg phosphatidylglycerol (PG), 
dimyristoylphosphatidylcholine (DMPC), dimyristoylphosphatidylglycerol (DMPG), 
cholesterol and sphingomyelin were provided by Avanti Polar Lipids. 1,6-dyphenyl-1,3,5-
hexatriene (DPH) and 1-(4-(trimethylammoniumphenyl)-6-phenyl-1,3,5-hexatriene (TMA-
DPH) were purchased from Molecular Probes. All other reagents were from Merck. 
 
Synthesis of peptides. Synthesis was carried out on an automated multiple peptide 
synthesizer (AMS 422, Abimed) using a solid-phase procedure and a standard Fmoc 
chemistry in a base of 25 µmol. It was used a N-α-Fmoc-DMP resin [4-(2=, 4=-
dimethoxyphenyl-Fmoc-aminomethyl)phenoxy resin (Novabiochem) with Fmoc-protected 
amino acids activated in situ with PyBop (benzotriazole-1-yl-oxi-tris-
pyrrolidinophosphonium hexafluorophosphate) in the presence of N-methylmorpholine and 
20% piperidine/dimethylformamide for deprotection. The protecting side-chain groups 
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were as follows: Asn and Gln (Trt), Glu (OtBu), Ser (tBu), Lys and Trp (Boc) and Cys 
(Acm). Peptides were cleaved from the resin with 82.5 % triflluoroacetic containing 5% 
phenol, 5 % water, 5 % thioanisole, 2.5 % ethane dithiol as scavengers (25), precipitated 
and washed with cold mehyl tert-buyl ether, water-extracted, lyophilized and purified by 
reverse-phase HPLC using a SuperPac7 Pep-S C2/C18 column (Pharmacia). Two different 
systems were used to purify the peptides. The non-acylated and myristoylated peptides 
were dissolved in  5% Acetonitrile in 0.1% trifluoroacetic acid (TFA) and a gradient of 
acetonitrile/0.1% TFA from 5 to 60% in 35 min and from 60 to 100% in 5 min was 
employed to elute them at a flow rate of 1 ml/min. In the case of palmitoylated and dually 
acylated peptides, ethanol (60%, v/v) in 0.1% TFA served as initial mobile phase, and 
peptides were eluted with a 5-100% linear gradient of propan-2-ol/0.1%TFA, in 35 min at 
0.7 ml/min. The absorbance at 214 nm was monitored continuously and relevant peaks 
were collected manually, pooled and lyophilized. The purified peptides were characterized 
by amino acid analysis, performed on a Beckman 6300 amino acid analyzer, PAGE 
electrophoresis, HPLC and fast atom bombardment mass spectrometry using a Bruker mod. 
Reflex III mass spectrometer. Due to the low solubility of peptides in aqueous buffers, a 5-
10 mg/ml stock solution of the peptide in trifluoroethanol (TFE) or dimethylsulfoxide 
(DMSO) was used in the various assays described in this work and kept a -20 oC between 
uses. The final organic solvent concentration was always kept under 2% (v/v).  
 
Acylation of peptides. Myristoylation and palmitoylation of peptides were performed on 
the synthesis resin. The myristic acid was activated with diciclohexylcarbodimide that 
renders the asymmetric anhydride and added in excess to the peptide attached to the resin. 
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This causes the formation of the amide bond. Once the peptide was myristoylated, it was 
cleaved from the resin. The palmitoylation was carried out according to the protocol of 
Beeckman et al. (26). After the synthesis, the protected peptide-resin was washed with 
dimethylformamide (DMF) and the side chains of cysteine residues were liberated with 0.1 
M mercury acetate in DMF. After completion of the reaction the resin was washed 
copiously with DMF. Then, the sulfhidryl groups were reduced with β-
mercaptoethanol/DMF (9:1) for three hours. Free SH groups were palmitoylated on the 
resin by coupling using 8 eq. of PyBop, 8 eq. of palmitic acid, 16 eq. of 
diisopropylethylamide (DIEA) in DMF, for 16 hours at 37 oC. Then, the peptide was 
cleaved from the resin. 
 
Vesicle preparation. In all cases a lipid film was obtained by drying a chloroform 
solution of the lipid under a current of nitrogen; this film was kept under vacuum for 5 
hours. The phospholipid was resuspended at a concentration of 1 mg/ml in medium buffer 
(5 mM Tris, pH 7.0, 100 mM NaCl, 5 mM MES, 5 mM sodium citrate, 1 mM EDTA) or 20 
mM sodium phosphate buffer, pH 7.0 for 1 hour at 37 oC and eventually vortexed. This 
suspension was sonicated in a bath sonicator (Branson 1200), and was subsequently 
subjected to at least 15 cycles of extrusion in a Liposofasttm-Basic apparatus (Avestin) with 
100 nm polycarbonate filters (Avestin). A 0.14 mM final phospholipid concentration was 
used in all the experiments. 
 
Circular dichroism measurements. Circular dichroism spectra were obtained on a Jasco 
J-715 spectropolarimeter using a 0.1 cm pathlength cuvette at 25 EC. The peptide 
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concentration employed was 80 µM. The buffer used was 20 mM sodium phosphate, pH 
7.0 or TFE. A minimum of four spectra was accumulated for each sample and the 
contribution of the buffer was always subtracted. The resultant spectra were smoothed 
using J-715 Noise Reduction software. The values of mean residue molar ellipticity [Θ]MRW 
were calculated on the basis of 100 as the average molecular mass per residue and they are 
reported in terms of degree x cm2 x dmol-1. The spectra in the presence of lipid vesicles were 
recorded after incubating for 1 h at 37 oC. To minimize the effect of light scattering on the 
shape and magnitude of the spectrum, lipid-peptide mixtures were sonicated before the spectra 
were recorded. 
 
Fluorescence measurements. Fluorescence studies were carried out on a SLM Aminco 
8000C spectrofluorimeter, fitted with a 450 W xenon arc and equipped with Glan 
Thompson polarizers. A 0.2x1 cm quartz cuvette was used. The buffer used was medium 
buffer, pH 7.0. The peptide concentration was 3 µM and the lipid concentration was 0.14 
mM. The temperature in the cuvette was maintained by a Polystat Hubber circulating water 
bath. Excitation was performed at 275 nm, and the emission spectra were recorded over the 
range 285-450 nm. The contribution of the buffer was always subtracted. 
 
Fluorescence polarization. Two different probes were employed in the depolarization 
experiments: 1,6-dyphenyl-1,3,5-hexatriene (DPH) and 1-(4-(trimethylammoniumphenyl)-
6-phenyl-1,3,5-hexatriene (TMA-DPH). The former was dissolved in tetrahydrofuran and 
added to the lipid chloroform solution at a 1:500 molar ratio, and the latter was dissolved in 
methanol and added to the lipid chloroform solution at a 1:100 molar ratio. The lipid was 
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hydrated in medium buffer at a concentration of 1 mg/ml. The sample was divided into 0.5 
ml aliquots, each of them at 0.14 mM lipid concentration. DMSO was added to one of these 
aliquots (control) and peptide from a concentrated DMSO stock solution was added to the 
others (0.4, 1.4 and 4 µM final concentration). The samples were measured in 0.2x1 cm 
fluorescence cuvettes. The temperature in the cuvette was maintained by a Polystat Hubber 
circulating water bath. Excitation was performed at 365 nm and the emission wavelength 
was 425 nm. 
 
RESULTS 
 
Solid-phase synthesis and acylation of peptides. Following the methods described under 
Experimental Procedures, four peptides of 29 amino acids corresponding to the amino-
terminal region of eNOS have been obtained: non-acylated peptide (eNOS), myristoylated 
peptide (myr-eNOS), doubly palmitoylated peptide (eNOS-pal) and dually myristoylated 
and palmitoylated peptide (myr-eNOS-pal) (Table 1). All peptides were purified by 
reverse-phase HPLC. eNOS and myr-eNOS were dissolved in 0.1% TFA/5% acetonitrile 
and separated  with a gradient of acetonitrile. The increased hidrophobicity of eNOS-pal 
and myr-eNOS-pal made necessary to dissolve them in 0.1% TFA/60% ethanol and use a 
gradient of 5-100 % propan-2-ol to separate them. Figure 1 shows representative HPLC 
profiles of purified peptides. All the peptides eluted as single peaks. Incorporation of the 
myristic acid to the eNOS sequence considerably increased the elution time (from 21.7 to 
25.2 min). The presence of two palmitic acids rendered a peptide which eluted at almost 
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85% propan-2-ol while the additional myristic acid present in myr-eNOS-pal made the 
peptide to elute at 100% propan-2-ol. The identity of the peptides was confirmed by amino 
acid analysis and mass spectrometry. Table 2 shows the molecular mass obtained by mass 
spectrometry. The experimental data are virtually identical to the values calculated from the 
amino acid sequence. 
 
CD spectra of peptides. The conformation of the peptides was determined by circular 
dichroism. Figure 2 shows the far-UV circular dichroism spectra of non-acylated and 
acylated peptides in aqueous buffer and in the presence of an organic solvent, TFE. In 
aqueous solutions, eNOS showed a CD spectrum characteristic of a non-ordered structure 
with a minimum centered near 200 nm and a shoulder at 220 nm. However, the acylated 
peptides showed a shift of the minimum to higher wavelength, showing spectra with a 
minimum at 220 nm. In spite of the differences in the magnitude of the spectra of acylated 
peptides the spectral features are different from the non-acylated and are those of extended 
structures. The increased population of ordered conformations upon introduction of 
myristoyl and palmitoyl groups should be the result of the hydrophobic environment 
provided by the acyl chains. TFE has been used to identify the propensity of a polypeptide 
sequence to adopt ordered structures. When all four peptides are dissolved in 100 % TFE 
their spectra showed a maximum at 190 nm and two minima at 205 and 220 nm, with molar 
ellipticity values ranging from -13700 for myr-eNOS-pal to -15500 deg cm2 dmol-1 for 
eNOS (Figure 2). These are characteristics of peptides adopting a α-helical conformation.  
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Interaction of the peptides with phospholipid vesicles. To explore the ability of the 
peptides to interact with model membranes of different composition two different 
approaches have been used: fluorescence emission spectra of peptides in presence of lipid 
vesicles and fluorescence depolarization of two probes embedded in the bilayer to monitor 
changes in the transition properties of the phospholipids. 
 The peptides have been designed to contain a tryptophan residue at position 29 
which would serve as a fluorescent probe to monitor the interaction with lipid vesicles. One 
end of the molecule was chosen because of the minimal induced conformational 
perturbation and the C-terminal one because the N-terminal Gly had to be myristoylated. 
The fluorescence emission spectra of eNOS and acylated peptide alone or in presence of 
PC and PG vesicles are depicted in Figure 3. The position of the maximum of the emission 
spectra of eNOS peptide (354 nm) in medium buffer was indicative of a highly exposed 
environment of the tryptophan residue (27). Acylation with myristic acid did not modify 
the position of the maximum but the palmitate induced a significant decrease (347.5-349 
nm). Moreover, the acyl chains caused a decrease in the quantum yield of tryptophan in 
such a way that independently of the fatty acid content the fluorescence intensity was 
reduced to 50% of the original value (Figure 3B-D, solid lines). 
 When PC vesicles were added to eNOS peptide a slight decrease of the fluorescence 
intensity was observed without modifying the position of the maximum while the presence 
of PG vesicles also reduced slightly the fluorescence intensity but shifted the position of the 
maximum of the spectrum of eNOS to a lower wavelength (349 nm) (Figure 3A). The 
fluorescence properties of acylated peptides were modified upon interaction with neutral 
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and acidic phospholipids vesicles. The Trp residue occupied a more hydrophobic 
environment as a consequence of the interaction as evidenced by the blue shift of the 
fluorescence maximum (from 355-349 to 348-341 nm). On the other hand, the fluorescence 
intensity increased upon interaction being the increase much higher in the presence of PG 
than of PC. In fact, the fluorescence intensity at the maximum of the spectrum of myr-
eNOS-pal in the presence of PG is almost double of that of the parent peptide, eNOS. Thus, 
the fluorescence quenching which appears as a consequence of acylation completely 
disappears upon interaction with negatively charged phospholipids. This would be 
indicative of a conformational change which moves further away the Trp from the side 
chains responsible of the quenching.  
 The effect of eNOS and acylated peptides on the thermotropic behavior of synthetic 
phospholipids was assessed by fluorescence depolarization of DPH and its polar derivative 
TMA-DPH incorporated into the bilayer. The peptides were allowed to interact with 
DMPC and DMPG vesicles for 1 hour at 37 oC. The two fluorescent probes were employed 
in the assays so that the fluidity of both the inner and the outer part of the bilayer could be 
monitored. DPH is assumed to be aligned with the phospholipid acyl chains giving 
information of the hydrophobic core of the bilayer (28, 29), whereas TMA-DPH has a 
shallower location due to the anchoring of its non-fluorescent polar moiety to the 
lipid/water interface and interacts with both the phospholipid polar head groups and the 
fatty acyl chain region, probably as far down as C8-C10 (30, 31). 
 The addition of acylated peptides to PG and PC vesicles modified the phase 
transition curves mainly decreasing the fluidity of the bilayers above the transition 
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temperature. Thus, the amplitude of the phase transition was considerably reduced without 
significantly affecting the gel-to-liquid crystalline transition temperature. In order to 
compare the effect of the peptides on the thermotropic behavior of DMPC and DMPG 
phospholipids, the changes in the amplitude of the thermal transition (∆P) at increasing 
peptide concentrations for DPH- and TMA-DPH-labeled phospholipids were plotted 
(Figure 4). It can be observed that eNOS peptide did not produce any effect on the 
transition of neutral phospholipids independently of the probe used or the peptide 
concentration employed (Figure 4A,C) and only a small decrease of the ∆P value was 
observed when a 4 µM concentration was added to DPH-labeled DMPG vesicles,  affecting 
the phospholipids acyl chain in its fluid state. However, the acylated peptides decreased the 
amplitude of the thermal transition in a concentration dependent manner. At 4 µM peptide 
the transition of DPH-labeled DMPC vesicles is almost completely abolished when 
myristoylated, palmitoylated and dually acylated peptides were present (Figure 4A). When 
acidic vesicles were used, only myr-eNOS-pal cancelled the transition at the maximum 
concentration employed although the other two peptides also affect the microviscosity 
above the transition temperature, being higher the effect of eNOS-pal than that of myr-
eNOS. When TMA-DPH was used to monitor less deep domains similar results were 
obtained except that only the dually acylated peptide was able to cancel the transition and 
that the myr-eNOS induced more significant changes than eNOS-pal in TMA-DPH-labeled 
DMPC vesicles (Figure 4C). Control experiments carried out in the presence of equivalent 
concentrations of the free fatty acid (myristic or palmitic acid) indicated that all the effects 
should be due to the amino acid moiety of the acylated peptide since the acyl chain did not 
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modify either the order parameter nor the transition temperature (data not shown). Then, 
the presence of any fatty acids allows the peptide to interact with hydrophobic domains of 
the bilayer. 
 The effect of the peptides on the thermal transition of more complex vesicles was 
also studied. Figure 5 shows the fluorescence depolarization profiles of DPH-labeled 
DMPC vesicles containing 10 % of both cholesterol and sphingomyelin, two lipids present 
in the lipid composition of caveolae, alone and in the presence of 0.14 µM and 1.4 µM 
peptide concentrations. The thermal transition of the vesicles in the absence of peptide is 
less steep than that of pure DMPC because of the presence of cholesterol. The addition of 
cholesterol to a pure phospholipid bilayer abolishes the normal sharp thermal transition 
between gel and liquid crystalline (lc) phases, giving the membrane properties intermediate 
between two phases (32). Below the Tm, cholesterol weakens the packing of the headgroup 
increasing the fluidity of the ordered gel phase while above the Tm the reduction in freedom 
of acyl chains causes the membrane to condense with a concomitant decrease in fluidity 
(33). At 0.4 µM peptide concentration only myr-eNOS-pal diminished the transition 
amplitude affecting the acyl chain mobility both below and above the transition 
temperature. While myr-eNOS and eNOS-pal reduce the transition amplitude by 30% 
affecting only the acyl chains in the fluid state the dually acylated peptide almost 
completely cancelled the transition at 1.4 µM.  
 
CD of mixtures peptide-phospholipid. The CD spectra of the peptides in the presence of 
lipid vesicles of both acidic and neutral phospholipids are shown in Figure 6. The spectra 
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shown are those obtained at a protein:lipid ratio of 1:10 although it was observed a gradual 
change of the spectrum from the one in the absence of added phospholipids vesicles to the 
one at that protein:lipid ratio. Increasing the lipid concentration did not modify the 
spectrum any further. When challenged by either DMPG or DMPC vesicles the peptides 
underwent conformational changes as indicated by the CD spectra. The largest change 
corresponded to eNOS peptide. From an existing non ordered conformation the peptide 
adopted an extended conformation, featured by a minimum at 213 nm, in the presence of 
DMPG. However, the presence of DMPC did not modify the shape of eNOS peptide 
spectrum and only a decrease of the molar ellipticity values was observed (from -5070 at 
199 nm to -12200 deg cm2 dmol-1 at 201 nm). This fact could be due to the presence of less 
aggregated structures on the surface of the bilayer (34). 
 The extended conformation induced by acylation, characterized by a spectrum with 
a minimum at 216-218 nm is modified somehow as a consequence of the interaction with 
acidic phospholipids since a small shift of the position of the minimum and a decrease in 
the ellipticity value were observed. The spectra of acylated peptides in presence of DMPG 
vesicles were similar with a minimum at 214-219 nm and ellipticity values ranging -10700 
for myr-eNOS, -11200 for eNOS-pal and -12800 deg cm2 dmol-1 for myr-eNOS-pal (Figure 
6). The interaction of acylated peptides with neutral phospholipids modified the CD 
spectrum to a smaller extent. In the presence of DMPC vesicles, the CD spectra of 
myristoylated, palmitoylated or dually acylated peptides exhibited a minimum centered at 
218-222 nm and molar ellipticity values ranging from -5800 to -6900 deg cm2 dmol-1 
(Figure 6).  
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DISCUSSION 
 
Covalent attachment of fatty acids to proteins is a common form of protein modification 
which has been shown to influence both structure and interaction with membranes. To shed 
some light on the membrane-perturbing properties of acylated proteins we have synthesized 
a 28 amino acids peptide corresponding to the N-terminal region of endothelial nitric oxide 
synthase, eNOS. Two targeting signals seem to be contained within the eNOS sequence. To 
begin with, the N-terminus end of the protein, which is irreversibly myristoylated, can 
become reversibly palmitoylated at positions 15 and 26, in a process known to be involved 
in caveolar translocation. On the other hand, mutagenesis data seem to indicate that 
residues 350-358 of eNOS directly interact with caveolin-1 within endothelial cells hence 
modulating its enzymatic activity (35). In vivo, the subcellular localization of the 1203 
amino acid eNOS is dictated by its N-terminus end. In fact, constructs of the first 35 (20) or 
55 amino acids (14) of eNOS are sufficient to determinate a subcellular distribution similar 
to the wild-type protein. We might, therefore, infer that all the information necessary for 
the subcellular targeting of eNOS might be contained within these first 30 residues. With 
that in mind, we have analysed the structural and functional properties of the isolated N-
terminus end of eNOS in order to inspect if its translocation to sphingomyelin-cholesterol 
enriched caveolar subdomains can be attributed to the acylation state. Consequently, in our 
system, the effect of the caveolin-1-eNOS direct interaction does not contribute to the 
peptide-lipid interactions that we observed, allowing us to study each effect in isolation. 
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From the original sequence we have obtained three additional peptides with different 
degree of acylation: myristoylated, doubly palmitoylated and dually myristoylated and 
palmitoylated. The four peptides are highly pure as demonstrated by HPLC, amino acid 
analysis and mass spectrometry. 
From a structural point of view it has been previously shown both that palmitoyl groups 
increase (36) and decrease (37) the helical content of pulmonary surfactant protein-C. CD 
spectra show that the peptide corresponding to the N-terminal sequence of eNOS owns a 
great conformational flexibility being able to adopt different secondary structures when 
challenged by different types of environment. Thus, eNOS peptide has a non-ordered 
conformation in phosphate buffer. When the peptide is dissolved in TFE, a solvent which 
can induce stable conformations in peptides which are unstructured in solution (38), it 
adopts mainly a helical conformation. However, acylation itself, either myristic and/or 
palmitic, confers the peptide the ability to adopt extended conformations, indicated by the 
fact that the CD spectrum of all acylated peptides has a minimum at 220 nm characteristic 
of β-sheet. On the other hand, the fact that eNOS and acylated peptides show different 
fluorescence emission maxima could suggest that acylation causes peptide aggregation or 
micelle formation (39) although the conformational changes observed by CD spectra could 
also be responsible for the more hydrophobic environment of the Trp residue. Although N-
terminally truncated eNOS have been crystallized and their atomic structure obtained, none 
of them contain the sequence stretch described in this work. We have demonstrated herein 
that the myristoylated N-terminal amino-acid peptide of eNOS adopts a β-strand 
conformation in solution. This observation strongly suggests, although it does not confirm, 
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that this extended conformation might adopt a β-strand that could associate with the N-
terminal β-sheet lariat observed in the truncated three-dimensional structure obtained from 
crystallographic data (40). 
 With respect to the role of acylation on the interaction with membranes, there are 
controversial examples in the literature. Thus, it has been shown that the N-terminal 
segment of pulmonary surfactant lipopeptide SP-C has intrinsic propensity to interact with 
phospholipids bilayers in the absence of acylation (41). However, palmitoylation of 
peptides derived from the cysteine-rich domain of SNAP-23 is essential for membrane 
association (42). In several other cases a lipid moiety represents an additional binding 
energy necessary to achieve stable interactions (for a review see 43). 
 In the cellular cytoplasm, only two of the four peptide species that we describe in 
this work are present, that is myr-eNOS and myr-eNOS-palm. According to the circular 
dichroism data, both of them are able to display very similar secondary structures both in 
solution and in association with vesicles composed of DMPC or DMPG. However, both of 
them display distinct degree of perturbation of the lipidic moiety according to our 
fluorescence spectra and fluorescence depolarization measurements. Fluorescence 
polarization studies show that the polypeptide sequence corresponding to the N-terminal 
region of eNOS is able to interact with model membranes composed of acidic 
phospholipids although the reduction of the transition amplitude is much smaller than that 
induced by any of the acylated peptides and only is observed at the highest concentration 
assayed. Probably the effect is promoted by the net charge that this amino acid sequence 
possesses, +2. As a consequence of this ionic interaction the peptide adopts a β-sheet like 
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structure. However, the behavior observed for the acylated peptides is that of an integral 
membrane protein which strongly restricts the mobility of the phospholipids acyl chains, 
suggesting the insertion of the peptide into the membrane. At a peptide concentration of 4 
µM, myr-eNOS-pal completely abrogated the thermal transition which indicates that the 
peptide interacts with the hydrophobic portion of the bilayer, preventing part of the 
phospholipids molecules from undergoing the transition characteristics of pure 
phospholipids species (44). Since equivalent amounts of the corresponding free fatty acid 
had no effect on the thermotropic behavior of the phospholipids it seems reasonable to 
conclude that the effect of acylated peptides are due to the insertion of the peptide into the 
hydrophobic core of bilayer probably mediated by the interactions between the fatty acid 
moiety of the peptide and the acyl chains of the phospholipids. The fact that acylated 
peptides are able to insert into bilayers of both neutral and acidic phospholipids point out 
that hydrophobic interactions are more important than ionic ones in eliciting the effects 
observed for these peptides. 
 The interaction of the peptides with phospholipids vesicles brings about 
conformational changes as indicated by fluorescence spectroscopy and circular dichroism. 
The largest change takes place when eNOS interacts with acidic phospholipids since from a 
non-ordered structure the peptide adopts spectroscopic features of extended conformations. 
The changes are higher upon interaction with acidic than with neutral phospholipids 
although in both cases the spectral features of an extended conformation are maintained. 
Then, it seems clear that there exists a high tendency of the N-terminus of eNOS to 
associate with acidic phospholipids. Remarkably, negatively charged phospholipids such as 
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phosphatidylserine and phosphatidylglycerol are known to inhibit eNOS activity through its 
binding to the calmodulin-binding amphipathic helix that interconnects both domains (45). 
Hence, the N-terminus end of eNOS might target the protein to membrane areas enriched in 
negatively charged phospholipids, where the reported inhibition might exist. When the 
intracellular calcium levels are raised, and calmodulin binding to eNOS activated the 
electron transfer and CNO synthesis, this inhibitory association with phospholipids might be 
lost (45). 
 Finally, another role of lipid modification is to promote membrane targeting. It is a 
general trend that a single lipophilic modification is not sufficient to target a protein to a 
specific membrane and two lipid moieties are necessary (43). Specifically, myristate and 
palmitate are necessary and sufficient to promote targeting to rafts (46, 47). In the case of 
eNOS it has been shown that palmitoylation only takes place in protein molecules which 
have been previously myristoylated (14). Since this protein is regulated through a 
palmitoylation-depalmitoylation cycle, it would be transiently associated with cholesterol-
sphingolipid-enriched subdomains present in the cellular membrane (48, 49). 
 It is remarkable that in pure PC liposomes, the myr-eNOS peptide and the myr-
eNOS-pal peptide display similar membrane-perturbing properties at a 1.4 µM peptide 
concentration (Fig. 4A). Interestingly, when we introduce cholesterol/sphingomyelin at low 
levels (Fig. 5A or B) the perturbation exerted by the tri-acylated peptide becomes much 
more profound. This observation clearly states that palmitoylation per se of previously 
myristoylated sequences introduces a strong tendency to partition into l0 lipid domains, 
characteristic of lipid rafts. Moreover, since the amino acid sequence of all the peptides is 
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the same and only myr-eNOS-pal seems to specifically interact with rafts, the hydrophobic 
interactions of both myristic and palmitic acids should be responsible of the targeting 
specificity. However, it has been recently shown that short sequences such as Gly-Cys 
bearing only palmitoyl group both at the N-terminal and at the side chain of Cys can 
associate with raft domains (50). This would mean that the amino acid sequence also play a 
role in determining their association with a lipid bilayer. Since no proteins are incorporated 
into our vesicles, it can be inferred that partitioning of eNOS protein in particular and 
dually acylated proteins in general into rafts is due to the association of their acylated 
sequences with lipid rafts without requiring protein-protein interactions. 
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TABLES 
 
Table 1. Synthesized peptides corresponding to the N-terminal sequence of eNOSa.
Peptide Sequence 
eNOS GNLKSVGQEPGPPCGLGLGLGLGLCGKQW 
myr-eNOS myr-GNLKSVGQEPGPPCGLGLGLGLGLCGKQW 
eNOS-pal GNLKSVGQEPGPPC(pal)GLGLGLGLGLC(pal)GKQW 
myr-eNOS-pal myr-GNLKSVGQEPGPPC(pal)GLGLGLGLGLC(pal)GKQW 
 
a myr, myristic acyl chain; pal, palmitic acyl chain. The tryptophan residue added is 
showed in bold. 
 
Table 2. Molecular mass of synthesized peptides of the N-terminal sequence of eNOS. 
 
Peptide Calculated mass a (Da) m/z (Da) 
eNOS 2836.3 2834.2 
myr-eNOS 3046.5 3046.2 
eNOS-pal 3312.7 3310.6 
myr-eNOS-pal 3522.9 3520.7 
 
a The mass of peptides was calculated from the amino acid sequence of peptides and taking 
into account molecular mass of myristic acid (228.21) and palmitic acid (256.24). 
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LEGENDS 
 
FIGURE 1. HPLC elution profile of reverse phase purified peptides. (A) eNOS; (B) myr-
eNOS; (C) eNOS-pal; (D) myr-eNOS-pal. Peptides were purified by a 5-100% acetonitrile 
gradient (A, B) or a 5-100% Propan-2-ol linear gradient (C, D). The elution times are 
indicate. 
 
FIGURE 2. Far-UV circular dichroism spectra of eNOS and its acylated peptides alone or in 
the presence of TFE. (A) eNOS; (B) myr-eNOS; (C) eNOS-pal; (D) myr-eNOS-pal. (!) 20 
mM sodium phosphate, pH 7.0; (○) 100% TFE. The peptide concentration was 80 µM. These 
spectra are representative of those obtained for three different preparations. 
 
FIGURE 3. Fluorescence emission spectra of eNOS and its acylated peptides in the presence 
of lipid vesicles. (A) eNOS; (B) myr-eNOS; (C) eNOS-pal; (D) myr-eNOS-pal. Medium 
buffer (solid line); PC vesicles (short-dashed line); PG vesicles (long-dashed line). Emission 
spectra were obtained upon excitation at 275 nm. The protein concentration was 3 µM and 
lipid concentration was 0.14 mM. The buffer employed was medium buffer, pH 7.0.  
 
FIGURE 4.  Changes in the amplitude of the thermal transition (∆P) of DPH (A, B) and TMA-
DPH (C, D)-labeled DMPC (A, C) and DMPG (B, D) vesicles with increasing peptide 
 37
concentration. () eNOS; (∆) myr-eNOS; () eNOS-pal; ({) myr-eNOS-pal. ∆P value is 
defined as the difference between the fluorescence polarization values measured at 10 and 45 
oC. The phospholipid concentration was 0.14 mM. 
 
FIGURE 5. Fluorescence polarization of DPH-labeled DMPC-10% Cho-10% SM vesicles. 
(z) vesicles alone; ({) eNOS; (–) myr-eNOS; (V) eNOS-pal; ( ) myr-eNOS-pal. The 
phospholipid concentration was 0.14 mM and the peptide concentrations were 0.4 µM (A) and 
1.4 µM (B).  
 
FIGURE 6. Far-UV circular dichroism spectra of eNOS and its acylated peptides in the 
presence of DMPC or DMPG vesicles. (A) eNOS; (B) myr-eNOS; (C) eNOS-pal; (D) myr-
eNOS-pal. (z) peptide alone; (–) DMPG vesicles; ({) DMPC vesicles. The peptide 
concentrations was 80 µM. The peptide:lipid ratio was 1:10. The buffer employed was 20 
mM sodium phosphate, pH 7.0. These spectra are representative of these obtained for three 
different preparations. 
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